The Europe Gas Exchange Pulmonary Function Testing Market is expected to grow with a CAGR of 7.5% in the forecast period. The years considered for the study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/es/reports/europe-gas-exchange-pulmonary-function-testing-market
The Europe gas exchange pulmonary function testing market is a highly consolidated market, which includes a specific number of key players and local players. The market has witnessed increased strategic developments owing to favorable market scenarios.
The major players dealing in the Europe gas exchange pulmonary function testing market are introducing a robust range of product portfolios. This helped companies to maximize sales with enhanced gas exchange pulmonary function testing and product portfolios.
For instance,
- In April 2021, VYAIRE had declared the launch of ARTIQ PFT. The ARTIQ PFT is an automated tool used in diffusion capacity, which uses artificial intelligence to interpret the pulmonary function test (PFT) results. The launch of the ARTIQ PFT would benefit pulmonologists, where the tool would deliver standardized and unbiased diagnostic interpretation in a fraction of a second. This can increase the net sales and demand of the customers, who are from hospitals and diagnostic laboratories
VYAIRE is the dominating market player in the Europe gas exchange pulmonary function testing market. Some of the major companies in the market are Geratherm Respiratory GmbH (A subsidiary of Geratherm), M.E.C. MEDICAL ELECTRONIC CONSTRUCTION, ECO MEDICS AG, PulmOne Advanced Medical Devices., Data Sciences International (A subsidiary of Harvard Bioscience), medical equipment europe GmbH, NDD Medical Technologies, MGC DIAGNOSTICS CORPORATION. (A subsidiary of ALTUS CAPITAL PARTNERS), SCHILLER, Medisoft Group, Biodex Medical Systems, Inc. (A subsidiary of MRI Technologies Inc), COSMED srl, PISTON MEDICAL, CARESTREAM MEDICAL, KoKo PFT, ASI Health Services, Swedish Health Services, Bellin Health Systems, among others.
VYAIRE
VYAIRE was founded in 2016 and had its base headquarters in Illinois, the U.S. It has private ownership. The company is the only global company focused exclusively on breathing through every stage of life. The company has various product categories such as Anesthesiology, Cardiology, Critical Care, Emergency Medicine, Infection, Control and Prevention, Neonatology, Operative Care, Pulmonology, Respiratory Therapy, Sports Medicine. The market-focused category is Pulmonology.
For instance,
- In January 2020, VYAIRE entered into a five-year agreement with Spirosure Inc to distribute Spirosure's Fenom Pro Asthma monitor in the United States, Germany, the Netherlands, and the U.K. The Fenom Pro is a gas exchange or diffusion capacity monitor, which measures FeNO, the biomarker for diagnosing and managing asthma. The five-year agreement would allow the distribution of Fenom Pro in the top diagnostic respiratory labs in the U.S. and Europe. This also increased the share of the pulmonology market in Europe in the coming years
The company has a presence in North America, Europe, Asia-Pacific. The subsidiaries are imtmedical ag (Switzerland), Ciel Medical (U.S.), ACUTRONIC Medical Systems AG (Switzerland), Revolutionary Medical Devices, Inc. (U.S.), VIASYS Holdings Inc (U.S.).
Geratherm Respiratory GmbH (A subsidiary of Geratherm)
Geratherm Respiratory GmbH is headquartered in Germany, Europe. It has private ownership. The company is an innovative partner for medical products in the field of spirometry, pulmonary function testing (PFT), and cardiopulmonary exercise testing (CPET). The product categories include Spirometery, PFT, CPET, Flow Concept. The market-focused category is PFT.
For instance,
- In January 2020, the Geratherm Respiratory Gmbh participated in a conference called Leading International Trade Fair in Germany to display the gas exchange pulmonary function test systems, such as the Diffustik. The conference had engaged market players around the Europe region for the delivery of the Diffustik. It had resulted in a rise in net sales
The company has a wide global presence across North America, Europe, Asia-Pacific, Middle East and Africa.
M.E.C. MEDICAL ELECTRONIC CONSTRUCTION
M.E.C. MEDICAL ELECTRONIC CONSTRUCTION was founded in 1984 and is headquartered in Pennyslavania, the U.S. It has private ownership. The company specializes its forefront of electronic cardiorespiratory and pulmonary function testing device distribution. The company offers a range of product categories such as Breath Test, Lung Function. The market-focused category is Lung Function.
The company has a global presence in Europe. There are no subsidiaries present.
